Outsourcing

Jun 10, 2016
By BioPharm International Editors
Brammer Bio establishes late-phase development and commercial manufacturing facility for advanced cell and gene therapies in Lexington, MA.
Jun 07, 2016
Uncertainty about the demand for a biologic medication can be partly mollified with some well-planned capacity outsourcing, contends a new report by ORC International sponsored by Patheon.
Jun 07, 2016
By BioPharm International Editors
The new company is the product of a merger with Formex.
Jun 02, 2016
BioPharm International
Acquisition binges often lead to hangovers; here’s what to watch out for.
May 31, 2016
BioPharm sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
May 01, 2016
BioPharm International
Growth may be slowing, but outsourcing activity remains healthy.
Apr 01, 2016
Contract biopharmaceutical manufacturing has been growing steadily and is expected to reach $4.1 billion by 2019.
Apr 01, 2016
BioPharm International
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
Mar 24, 2016
By BioPharm International Editors
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
Mar 01, 2016
BioPharm International
The authors provide their perspectives on shipping validation.
native1_300x100
lorem ipsum